-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Conduit Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2021 to Q2 2024.
- Conduit Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.38M, a 156% decline year-over-year.
- Conduit Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$5.69M, a 31.4% increase year-over-year.
- Conduit Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$535K, a 89.1% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)